Vivanos Health

Medical

Only for iPhone

Free

iPhone

Diabetes management app designed for use by Primary Care Providers for their patients. Disclaimer The use of this app is for informational purposes only and should not and cannot serve as a substitute for an examination and treatment by a qualified health care provider. Each person’s condition and situation is unique and individuals should consult a qualified health care provider for medical advice and answers to personal health questions. While this app attempts to be as accurate as possible, it should not be relied upon as being comprehensive or error-free. Citations Standards of Medical Care in Diabetes: Summary of Revisions. DIABETES CARE 2022;45 https://diabetesjournals.org/care/article/45/Supplement_1/S4/138912/Summary-of-Revisions-Standards-of-Medical-Care-in The Effect of Intensive Blood Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34). LANCET 1998;352:854. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)07037-8/fulltext Efficacy of Atenolol and Captopril in Reducing Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 39). BR MED J 1998; 317:713. https://pubmed.ncbi.nlm.nih.gov/9732338/ Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49). JAMA 1999: 281:2005. https://jamanetwork.com/journals/jama/fullarticle/190204 Intensive Blood Glucose Control with Sulfonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet 1998; 352:837. https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(98)07019-6.pdf Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 38). BMJ 1998; 317:703. https://pubmed.ncbi.nlm.nih.gov/9732337/ DCCT Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N ENGL J MED 1993; 329:977. https://www.nejm.org/doi/full/10.1056/nejm199309303291401

  • 5.0
    out of 5
    1 Ratings

- added maximum attempts - bug fixes

The developer, Vivanos Health, Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Health & Fitness
    • Identifiers

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Seller
  • Vivanos Health, Inc
Size
  • 10.6 MB
Category
  • Medical
Compatibility
Requires iOS 13.0 or later.
  • iPhone
    Requires iOS 13.0 or later.
  • iPod touch
    Requires iOS 13.0 or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
  • English
Age Rating
16+
Copyright
  • © 2025 Vivanos Health, Inc.